
FDA Commissioner David Kessler, M.D., is leaving after six years at the agency

Pharmaceutical Representative recently asked industry experts to predict the future. The following are their responses about the coming year.

Psychiatrists have developed new clinical guidelines for treating bipolar disorder and schizophrenia.

We asked top intellectual property lawyers about what the Supreme Courts decision will mean for pharma and biotech companies. Here is our forward-looking analysis of their comments.